OMB control number

[NCEZID] Risk factors, clinical course, presence and persistence of virus in various bodily fluids, and risk of sexual transmission among U.S. adults with Oropouche virus disease

OMB 0920-1446 ยท HHS/CDC.

OMB 0920-1446

Beginning in late 2023, Oropouche virus was identified as the cause of multiple outbreaks with over 10,000 cases from 6 countries reported in 2024 as of October 15. With these outbreaks, the virus was reported to cause disease cases in new non-endemic areas, result in the first reported deaths, be associated with fetal demise and congenital anomalies, and be found in the semen of an infected traveler. Although local transmission of the virus has not been detected yet in the United States, the vectors capable of transmitting the virus are present in many states and at least 90 cases of U.S. travelers returning to the United States while infected with the virus have been reported. All of these findings and factors, raise concerns about the broader threat this virus represents to the United States. There are numerous gaps in our understanding of this emerging virus, including the urgent need to evaluate the possibility of sexual transmission to inform prevention recommendations, especially for pregnant people and their partners, or those considering pregnancy. This re-instatement is submitted for the Initial Clinical and Social Survey, Contract Tracing Survey, and Sexual Contact Interview forms. The purpose of this change is to address feedback from state partners and streamline the data collection by providing clarifying language regarding the timeframes of interest for both individuals who consent to participate and staff conducting the interviews. There is no change to the overall burden hours previously approved for the 0920-1446 data collection.

The latest form for [NCEZID] Risk factors, clinical course, presence and persistence of virus in various bodily fluids, and risk of sexual transmission among U.S. adults with Oropouche virus disease expires 2028-08-31 and is listed under ICR 202506-0920-008.

Latest Forms, Documents, and Supporting Material

Latest forms, documents, and information collections
DocumentType
Form 0920-25AU Sexual Contact InterviewForm
Form 0920-25AU Sexual Contact Interview formForm
Form 0920-25AU Contact Tracing SurveyForm
Form 0920-25AU Contact Tracing SurveyForm
Form 0920-25AU Symptom DiaryForm
Form 0920-25AU Symptom DiaryForm
Form 0920-25AU Follow-up Clinical SurveyForm
Form 0920-25AU Follow-up clinical surveyForm
Form 0920-25AU Initial Clinical SurveyForm
Form 0920-25AU Baseline surveyForm
CSTE OROV Comments 7-11-2025.pdfPublic Comments
PC_202506-0920-008_071125_055555_1.pdfPublic Comments
Attachment_11_Consent_sexual_interview.docxSupplementary Document
Attachment_11_Consent_sexual_interview.docx Supplementary Document
Attachment_10_Consent_sample_collection.docxSupplementary Document
Attachment_10_Consent_sample_collection.docx Supplementary Document
Attachment_9_Consent_med_social.docxSupplementary Document
Attachment_9_Consent_med_social.docx Supplementary Document
Attachment_8_Background_info_FAQ.docxSupplementary Document
Emergency Request Memo_OROV Response_10.25.24.docxSupplementary Document
Emergency Request Memo_OROV Response_10.25.24.docx Supplementary Document
Att. 13 Privacy Impact Assessment-2.pdfSupplementary Document
Att. 12 Human Subjects Determination.pdfSupplementary Document
Att. 12 Human Subjects Determination.pdf Supplementary Document
Att. 1 Section 301 of the Public Health Service Act (42 USC 241).pdfSupplementary Document
Att. 1 Section 301 of the Public Health Service Act (42 USC 241).pdf Supplementary Document
Att A_Explanation for Program Changes_0920-1446_non-sub_29Nov2024.docxSupplementary Document
0920-1446 Change Request-2024 Oropouche Response_11.29.2024.docxJustification for No Material/Nonsubstantive Change
0920-1446 Change Request-2024 Oropouche Response_11.29.2024.docx Justification for No Material/Nonsubstantive Change
Att. 13 Privacy Impact Assessment.pdfSupplementary Document
Att. 13 Privacy Impact Assessment-2.pdfSupplementary Document
Att. 13 Privacy Impact Assessment-2.pdf Supplementary Document
Att. 12 Human Subjects Determination.pdfSupplementary Document
Att. 12 Human Subjects Determination.pdf Supplementary Document
Emergency Request Memo_OROV Response_10.25.24.docxSupplementary Document
Emergency Request Memo_OROV Response_10.25.24.docx Supplementary Document
Att. 11 Script and consent for sexual partner interview and OROV testing .docxSupplementary Document
Att. 11 Script and consent for sexual partner interview and OROV testing .docx Supplementary Document
Att. 9 Consent for medical and social information .docxSupplementary Document
Att. 9 Consent for medical and social information .docx Supplementary Document
Att. 8 Background information and frequently asked questions for participants .docxSupplementary Document
Att. 8 Background information and frequently asked questions for participants .docx Supplementary Document
Supporting Statement B_OROV Response_Revised_June_12__2025_clean.docxSupporting Statement B
Supporting Statement B_OROV Response_Revised_June_12__2025_clean.docxSupporting Statement B
Supporting Statement A_OROV Response_Revised_June_12_2025_clean.docxSupporting Statement A
Supporting Statement A_OROV Response_Revised_June_12_2025_clean.docxSupporting Statement A
Att. 1 Section 301 of the Public Health Service Act (42 USC 241).pdfSupplementary Document
Att. 1 Section 301 of the Public Health Service Act (42 USC 241).pdf Supplementary Document
Sexual Contact Interview form Form
Sexual Contact Interview form Form
Contact Tracing Survey Form
Contact Tracing Survey Form
Symptom Diary Form
Symptom Diary Form
Follow-up clinical survey Form
Follow-up clinical survey Form
Baseline survey Form
Baseline survey Form

All Historical Document Collections

Historical document collections
ReferenceFilingReceivedConcludedAction
202506-0920-008 Reinstatement without change of a previously approved collection 2025-06-26
202412-0920-003 No material or nonsubstantive change to a currently approved collection 2024-12-05 Approved without change
202410-0920-025 New collection (Request for a new OMB Control Number) 2024-10-28 Approved without change

OMB Details

Baseline survey

Federal Enterprise Architecture: Health - Public Health Monitoring

Information collection instruments
FormNameElectronic accessType
Form 0920-25AUInitial Clinical SurveyFillable FileableForm

Review document collections for all forms, instructions, and supporting documents - including paper/printable forms.